Literature DB >> 2501509

TEN versus TPN following major abdominal trauma--reduced septic morbidity.

F A Moore1, E E Moore, T N Jones, B L McCroskey, V M Peterson.   

Abstract

Recent animal models suggest that enteral feeding (TEN) compared to parenteral nutrition (TPN) improves resistance to infection. This prospective clinical trial examined the impact of early TEN vs. TPN in the critically injured. Seventy-five patients with an abdominal trauma index (ATI) greater than 15 and less than 40 were randomized at initial laparotomy to receive either TEN (Vivonex TEN) or TPN (Freamine HBC 6.9% and Trophamine 6%); both regimens contained 2.5% fat, 33% branched chain amino acids, and had a calorie to nitrogen ratio of 150:1. TEN was delivered via a needle catheter jejunostomy. Nutritional support was initiated within 12 hours postoperatively in both groups, and infused at a rate sufficient to render the patients in positive nitrogen balance. The study groups (TEN = 29 vs TPN = 30) were comparable in age, injury severity and initial metabolic stress. Jejunal feeding was tolerated unconditionally in 25 (86%) of the TEN group. Nitrogen balance remained equivalent throughout the study period, at day 5 TEN = -0.3 +/- 1.0 vs. TPN 0.1 +/- 0.8 gm/day. Traditional nutritional protein markers (albumin, transferrin, and retinol binding protein) were restored better in the TEN group. Infections developed in 5 (17%) of the TEN patients compared to 11 (37%) of the TPN group. The incidence of major septic morbidity was 3% (1 = abdominal abscess) in the TEN group contrasted to 20% (2 = abdominal abscess, 6 = pneumonia) with TPN. This clinical study demonstrates that TEN is well tolerated in the severely injured, and that early feeding via the gut reduces septic complications in the stressed patient.

Entities:  

Mesh:

Year:  1989        PMID: 2501509     DOI: 10.1097/00005373-198907000-00003

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  122 in total

1.  Common mucosal immunity: a novel hypothesis.

Authors:  F A Moore
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Small amount of low-residue diet with parenteral nutrition can prevent decreases in intestinal mucosal integrity.

Authors:  K Omura; K Hirano; E Kanehira; K Kaito; M Tamura; S Nishida; K Kawakami; Y Watanabe
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  Route and type of nutrition influence mucosal immunity to bacterial pneumonia.

Authors:  B K King; K A Kudsk; J Li; Y Wu; K B Renegar
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

Review 4.  Mechanisms of organ dysfunction in critical illness: report from a Round Table Conference held in Brussels.

Authors:  M P Fink; T W Evans
Journal:  Intensive Care Med       Date:  2002-02-08       Impact factor: 17.440

Review 5.  Enteral nutrition access devices.

Authors:  A Habib; D F Kirby
Journal:  Curr Gastroenterol Rep       Date:  1999-08

6.  Route of nutrition influences generation of antibody-forming cells and initial defense to an active viral infection in the upper respiratory tract.

Authors:  Cheryl D Johnson; Kenneth A Kudsk; Kazuhiko Fukatsu; Kathryn B Renegar; Ben L Zarzaur
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

Review 7.  Benefits and limitations of enteral nutrition in the early postoperative period.

Authors:  Christos Dervenis; Costas Avgerinos; Dimitrios Lytras; Spiros Delis
Journal:  Langenbecks Arch Surg       Date:  2003-02-07       Impact factor: 3.445

8.  Epidermal growth factor/TNF-α transactivation modulates epithelial cell proliferation and apoptosis in a mouse model of parenteral nutrition.

Authors:  Yongjia Feng; Daniel H Teitelbaum
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-10       Impact factor: 4.052

Review 9.  Hypermetabolism and Nutritional Support in Sepsis.

Authors:  John C Alverdy
Journal:  Surg Infect (Larchmt)       Date:  2018-02-02       Impact factor: 2.150

Review 10.  Enteral nutrition in the critically ill patient: a critical review of the evidence.

Authors:  D K Heyland; D J Cook; G H Guyatt
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.